The agency has ordered compounding pharmacies to stop making compound versions of GLP-1 drugs now that the drugs are no longer in short supply. Eli Lilly, the maker of Zepbound and Mounjaro, and Novo ...
The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...
For the second time, a federal judge has ordered the Trump administration to pay out money Congress appropriated to foreign ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback